Home
/
Pasithea Therapeutics Corp.
/
Financials
/
Quarterly
Pasithea Therapeutics Corp. — Quarterly Financials
Quarterly figures from SEC EDGAR XBRL filings (10-Q)
These figures are extracted from XBRL-tagged quarterly reports (10-Q) that Pasithea Therapeutics Corp. filed with the SEC. Values are as reported for each individual quarter (Q1, Q2, Q3, Q4) — not cumulative year-to-date. Negative figures indicate a loss.
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2022
Sep 30, 2022
$218.6K
Nov 14, 2022
Q2
2022
Jun 30, 2022
$13.6K
Aug 15, 2022
Q1
2023
Mar 31, 2022
$13.7K
May 12, 2023
Net Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
($3.04M)
Nov 13, 2025
Q3
2025
Jun 30, 2025
($3.72M)
Nov 13, 2025
Q2
2025
Jun 30, 2025
($3.72M)
Aug 14, 2025
Q3
2025
Mar 31, 2025
($3.56M)
Nov 13, 2025
Q2
2025
Mar 31, 2025
($3.56M)
Aug 14, 2025
Q1
2025
Mar 31, 2025
($3.56M)
May 15, 2025
Q3
2025
Sep 30, 2024
($3.00M)
Nov 13, 2025
Q3
2025
Jun 30, 2024
($3.87M)
Nov 13, 2025
Q2
2025
Jun 30, 2024
($3.87M)
Aug 14, 2025
Q1
2025
Mar 31, 2024
($3.86M)
May 15, 2025
Q2
2025
Mar 31, 2024
($3.86M)
Aug 14, 2025
Q3
2025
Mar 31, 2024
($3.86M)
Nov 13, 2025
Q3
2024
Sep 30, 2023
($3.61M)
Nov 13, 2024
Q2
2024
Jun 30, 2023
($3.76M)
Aug 13, 2024
Q3
2024
Jun 30, 2023
($3.76M)
Nov 13, 2024
Q3
2024
Mar 31, 2023
($3.54M)
Nov 13, 2024
Q1
2024
Mar 31, 2023
($3.54M)
May 14, 2024
Q2
2024
Mar 31, 2023
($3.54M)
Aug 13, 2024
Q3
2023
Sep 30, 2022
($4.59M)
Nov 13, 2023
Q3
2023
Jun 30, 2022
($2.66M)
Nov 13, 2023
Operating Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
($3.11M)
Nov 13, 2025
Q2
2025
Jun 30, 2025
($3.81M)
Aug 14, 2025
Q1
2025
Mar 31, 2025
($3.68M)
May 15, 2025
Q3
2025
Sep 30, 2024
($3.00M)
Nov 13, 2025
Q2
2025
Jun 30, 2024
($3.95M)
Aug 14, 2025
Q1
2025
Mar 31, 2024
($4.04M)
May 15, 2025
Q3
2024
Sep 30, 2023
($3.79M)
Nov 13, 2024
Q2
2024
Jun 30, 2023
($3.83M)
Aug 13, 2024
Q1
2024
Mar 31, 2023
($3.21M)
May 14, 2024
Q3
2023
Sep 30, 2022
($3.86M)
Nov 13, 2023
Q2
2023
Jun 30, 2022
($2.61M)
Aug 11, 2023
Q1
2023
Mar 31, 2022
($2.08M)
May 12, 2023
Q3
2022
Sep 30, 2021
($1.27M)
Nov 14, 2022
Q2
2022
Jun 30, 2021
($727.9K)
Aug 15, 2022
Q1
2022
Mar 31, 2021
($549.6K)
May 16, 2022
Q3
2021
Sep 30, 2020
($14.0K)
Nov 18, 2021